| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.03 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.03 |